Anika Therapeutics, Inc. (ANIK) AI Dilution Summary

The company is funding itself from cash on hand. Estimated cash was $38,412,000 as of 2026-06-30. That figure carries forward the $38,412,000 of cash at the 2026-06-30 balance-sheet date, against estimated monthly burn of $228,000.